125 related articles for article (PubMed ID: 36082608)
1. Selumetinib for Refractory Pulmonary and Gastrointestinal Bleeding in Noonan Syndrome.
Chakraborty A; Beasley G; Martinez H; Jesudas R; Anton-Martin P; Christakopoulos G; Kramer J
Pediatrics; 2022 Oct; 150(4):. PubMed ID: 36082608
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
3. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
[TBL] [Abstract][Full Text] [Related]
4. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease in Noonan syndrome.
Pierpont ME; Digilio MC
Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
[TBL] [Abstract][Full Text] [Related]
6. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
[TBL] [Abstract][Full Text] [Related]
7. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
[TBL] [Abstract][Full Text] [Related]
8. Successful use of extracorporeal membrane oxygenation for pulmonary embolism, prolonged cardiac arrest, post-partum: a cannulation dilemma.
Fernandes P; Allen P; Valdis M; Guo L
Perfusion; 2015 Mar; 30(2):106-10. PubMed ID: 25304130
[TBL] [Abstract][Full Text] [Related]
9. Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome During Hemorrhagic Shock.
Raff LA; Maine RG; Reid TS
ASAIO J; 2021 Aug; 67(8):e140-e144. PubMed ID: 33181542
[TBL] [Abstract][Full Text] [Related]
10. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
[TBL] [Abstract][Full Text] [Related]
11. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
Binder G; Neuer K; Ranke MB; Wittekindt NE
J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
[TBL] [Abstract][Full Text] [Related]
12. PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome.
Kosaki K; Suzuki T; Muroya K; Hasegawa T; Sato S; Matsuo N; Kosaki R; Nagai T; Hasegawa Y; Ogata T
J Clin Endocrinol Metab; 2002 Aug; 87(8):3529-33. PubMed ID: 12161469
[TBL] [Abstract][Full Text] [Related]
13. Mitral valve replacement and trans-mitral myectomy for a child with Noonan syndrome accompanied by hypertrophic obstructive cardiomyopathy.
Sasaki T; Asou T; Shirakawa M; Takahashi KI; Kunugi S; Nitta T
Gen Thorac Cardiovasc Surg; 2020 Apr; 68(4):380-384. PubMed ID: 30945161
[TBL] [Abstract][Full Text] [Related]
14. Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.
Linglart L; Gelb BD
Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):73-80. PubMed ID: 32022400
[TBL] [Abstract][Full Text] [Related]
15. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
Araki T; Mohi MG; Ismat FA; Bronson RT; Williams IR; Kutok JL; Yang W; Pao LI; Gilliland DG; Epstein JA; Neel BG
Nat Med; 2004 Aug; 10(8):849-57. PubMed ID: 15273746
[TBL] [Abstract][Full Text] [Related]
16. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N
Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561
[TBL] [Abstract][Full Text] [Related]
17. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction.
Gelb BD; Tartaglia M
Hum Mol Genet; 2006 Oct; 15 Spec No 2():R220-6. PubMed ID: 16987887
[TBL] [Abstract][Full Text] [Related]
18. Rapid progression of mitral valve disease in a child with Noonan syndrome.
Doctor PN; Lawrence DK; Misra A
Cardiol Young; 2020 Dec; 30(12):1964-1966. PubMed ID: 32985405
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.
Sznajer Y; Keren B; Baumann C; Pereira S; Alberti C; Elion J; Cavé H; Verloes A
Pediatrics; 2007 Jun; 119(6):e1325-31. PubMed ID: 17515436
[TBL] [Abstract][Full Text] [Related]
20. Aortic root dilatation is a rare complication of Noonan syndrome.
Power PD; Lewin MB; Hannibal MC; Glass IA
Pediatr Cardiol; 2006; 27(4):478-80. PubMed ID: 16830086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
